154 related articles for article (PubMed ID: 38338342)
21. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
22. Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling.
Wan L; Zhao Y; Zhang Q; Gao G; Zhang S; Gao Y; Chen X; Qian X
BMC Complement Altern Med; 2019 Dec; 19(1):359. PubMed ID: 31823762
[TBL] [Abstract][Full Text] [Related]
23. Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation.
Nakade J; Takeuchi S; Nakagawa T; Ishikawa D; Sano T; Nanjo S; Yamada T; Ebi H; Zhao L; Yasumoto K; Matsumoto K; Yonekura K; Yano S
J Thorac Oncol; 2014 Jun; 9(6):775-83. PubMed ID: 24828661
[TBL] [Abstract][Full Text] [Related]
24. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
[TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
26. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA
Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055
[TBL] [Abstract][Full Text] [Related]
27. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.
Awasthi N; Schwarz MA; Verma V; Cappiello C; Schwarz RE
Lab Invest; 2009 Jan; 89(1):38-46. PubMed ID: 19002109
[TBL] [Abstract][Full Text] [Related]
28. Antrodia cinnamomea produces anti-angiogenic effects by inhibiting the VEGFR2 signaling pathway.
Huang TT; Lan YW; Ko YF; Chen CM; Lai HC; Ojcius DM; Martel J; Young JD; Chong KY
J Ethnopharmacol; 2018 Jun; 220():239-249. PubMed ID: 29609012
[TBL] [Abstract][Full Text] [Related]
29. [Effects and mechanisms of Xiao-Ai-Ping injection on angiogenesis].
Wang MJ; Du DY; Fan W; Zhang C; Liu Y; Fan JH; Yuan ST; Lin SS
Yao Xue Xue Bao; 2016 Feb; 51(2):309-15. PubMed ID: 29856586
[TBL] [Abstract][Full Text] [Related]
30. Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2/Flk-1 in endothelial cells.
Zhao K; Li X; Lin B; Yang D; Zhou Y; Li Z; Guo Q; Lu N
J Cell Physiol; 2018 Apr; 233(4):3454-3464. PubMed ID: 28926106
[TBL] [Abstract][Full Text] [Related]
31. α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.
Saraswati S; Kumar S; Alhaider AA
Mol Cancer; 2013 Nov; 12():147. PubMed ID: 24261856
[TBL] [Abstract][Full Text] [Related]
32. Potent anti-angiogenic component in Kaempferia galanga L. and its mechanism of action.
Huang W; Zheng N; Niu N; Tan Y; Li Y; Tian H
J Ethnopharmacol; 2024 Apr; 324():117811. PubMed ID: 38286156
[TBL] [Abstract][Full Text] [Related]
33. The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells.
Wang S; Cai R; Ma J; Liu T; Ke X; Lu H; Fu J
Phytomedicine; 2015 Oct; 22(11):1017-26. PubMed ID: 26407944
[TBL] [Abstract][Full Text] [Related]
34.
Kim D; Kim KY
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830415
[TBL] [Abstract][Full Text] [Related]
35. Quercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cells.
Lin C; Wu M; Dong J
PLoS One; 2012; 7(2):e31708. PubMed ID: 22348123
[TBL] [Abstract][Full Text] [Related]
36. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
37. Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway.
Li B; Zhang Y; Yin R; Zhong W; Chen R; Yan J
Mediators Inflamm; 2020; 2020():1649453. PubMed ID: 33162828
[TBL] [Abstract][Full Text] [Related]
38. Platycodin D Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Blocking the Activation of Mitogen-Activated Protein Kinases and the Production of Interleukin-8.
Son JA; Lee SK; Park J; Jung MJ; An SE; Yang HJ; Son SH; Kim KR; Park KK; Chung WY
Am J Chin Med; 2022; 50(6):1645-1661. PubMed ID: 35848124
[TBL] [Abstract][Full Text] [Related]
39. The extract of Curcumae Longae Rhizoma suppresses angiogenesis via VEGF-induced PI3K/Akt-eNOS-NO pathway.
Guo GX; Wu KY; Zhang XY; Lai FX; Tsim KW; Qin QW; Hu WH
J Ethnopharmacol; 2023 May; 308():116299. PubMed ID: 36842721
[TBL] [Abstract][Full Text] [Related]
40. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Fan Y; Peng A; He S; Shao X; Nie C; Chen L
J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]